Champions Oncology Holds Annual Stockholder Meeting

Champions Oncology shareholders approved the 2026 Equity Incentive Plan at the annual meeting on October 14, 2026. Stockholders ratified EisnerAmper LLP as independent auditor for the fiscal year ending April 30, 2027. All seven director nominees were elected. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-066087), on October 16, 2026, and is solely responsible for the information contained therein. (C)